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Background:  Central (CSA) and obstructive (OSA) sleep apnea are frequently found in patients (pts) with chronic heart failure (CHF). Cardiac 
resynchronisation therapy (CRT) has been shown to improve CSA and prognosis in these pts. Aim of this study was to investigate the prognostic 
impact of CSA and OSA in a large cohort of pts after potential beneficial CRT effects have come into effect.
Methods:  In 202 consecutive CRT pts (63.2±10 years; 49 women) cardiorespiratory polygraphy was performed to screen for and determine type 
and severity of OSA or CSA. Pts were classified as noSDB if apnea-hypopnea-index (AHI) was < 5/h. CSA or OSA were classified according to the 
majority of events with an AHI of ≥ 5/h. Event free survival analysis was performed by standard methods of Kaplan-Meier-plots, Wilcoxon- and log-
rank-tests. Events were defined as death, cardiac transplantation or ventricular assist device implantation.
Results: CSA was documented in 35.6% (65±8 years, 86% men), OSA in 37.1% (64±9 years, 81% men) and noSDB in 27.2% (60±12 years, 55% 
men) of pts. Event free survival is shown in the figure.
Conclusions: SDB is diagnosed in two thirds of pts with long-term CRT. In these pts, CSA as well as OSA are associated with increased mortality. 
While continuous positive airway pressure (CPAP) therapy is now recommended by ESC guidelines, treatment of CSA by adaptive servoventilation 
(ASV) to improve outcome is currently under investigation.
 
